Adjuvants for human vaccines

Alving, CR; Peachman, KK; Rao, M; Reed, SG

HERO ID

1761372

Reference Type

Journal Article

Subtype

Review

Year

2012

Language

English

PMID

22521140

HERO ID 1761372
Material Type Review
In Press No
Year 2012
Title Adjuvants for human vaccines
Authors Alving, CR; Peachman, KK; Rao, M; Reed, SG
Journal Current Opinion in Immunology
Volume 24
Issue 3
Page Numbers 310-315
Abstract Rational selection of individual adjuvants can often be made on the basis of innate molecular interactions of the foreign molecules with pattern recognition receptors such as Toll-like receptors. For example, monophosphoryl lipid A, a family of endotoxic TLR4 agonist molecules from bacteria, has recently been formulated with liposomes, oil emulsions, or aluminum salts for several vaccines. Combinations of antigens and adjuvants with particulate lipid or oil components may reveal unique properties of immune potency or efficacy, but these can sometimes be exhibited differently in rodents when compared to nonhuman primates or humans. New adjuvants, formulations, microinjection devices, and skin delivery techniques for transcutaneous immunization demonstrate that adjuvant systems can include combinations of strategies and delivery mechanisms for uniquely formulated antigens and adjuvants.
Doi 10.1016/j.coi.2012.03.008
Pmid 22521140
Wosid WOS:000306450200011
Is Certified Translation No
Dupe Override No
Comments Source: Web of Science WOS:000306450200011
Is Public Yes
Language Text English